Intraarterial infusion of papaverine in experimental cerebral vasospasm

American Journal of Neuroradiology

Volumn 18, Issue 2, 1997, Pages 255-262

  Fujiwara, Naomi ^a,c   Honjo, Yasumasa ^a   Ohkawa, Motoomi ^a   Tanabe, Masatada ^a   Irie, Keiko ^a   Nagao, Seigo ^a   Takashima, Hitoshi ^a   Satoh, Katashi ^a   Kojima, Kanji ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA ROSAI HOSPITAL   (Japan)

^c NONE   (Japan)

Author keywords

Animal studies; Drugs, intraarterial infusion; Vasospasm

Indexed keywords

PAPAVERINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL DIAMETER; BRAIN BLOOD FLOW; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG INFUSION; EXPERIMENTAL MODEL; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY; MONKEY; NONHUMAN; SUBARACHNOID HEMORRHAGE;

ANIMALS; BLOOD FLOW VELOCITY; CAROTID ARTERY, INTERNAL; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; INFUSIONS, INTRA-ARTERIAL; ISCHEMIC ATTACK, TRANSIENT; MACACA; MALE; PAPAVERINE; RADIOGRAPHY, INTERVENTIONAL; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASODILATOR AGENTS;

EID: 0031045398     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Allcock JM, Drake CG. Ruptured intracranial aneurysms; the role of arterial spasm. J Neurosurg 1965;22:21-29
2. Kassell NF, Torner JC. The international cooperative study on timing aneurysm surgery: an update. Stroke 1984;15:566-570
3. Ropper AH, Zervas NT. Outcome 1 year after SAH from cerebral aneurysms: management morbidity, mortality, and functional state in 112 consecutive good-risk patients. J Neurosurg 1984;60:909-915
4. Findlay JM, Macdonald RL, Weir BKA. Current concept of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1991;3:336-361
5. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage. Ann Neurol 1983;14:599-608
6. Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage, I: incidence and effects. J Clin Neurosci 1994;1:19-26
7. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337-343
8. Wilkins RH. Attempt at prevention or treatment of intracranial arterial spasm: an update. Neurosurgery 1986;18:808-825
9. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FW Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365-372
10. Seiler RW, Reulen HJ, Heuber P, et al. Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intra-venous nimodipine, and transcranial Doppler ultrasound. Neurosurgery 1988;28:598-604
11. Mizoi K, Yoshimoto T, Fujisawa S, et al. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report. Neurosurgery 1.991;28:807-813
12. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 1984;70:65-79
13. Higashida RT, Halbach W, Cahan LD, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989;71:648-653
14. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR. Angioplasty for treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:654-660
15. Smith RR, Connors JJ, Yamamoto Y, Bernanke DH. Balloon angioplasty for vasospasm; theoretical and practical considerations. In: Sano K, ed. Cerebral Vasospasm. Tokyo, Japan: University of Tokyo Press; 1990:415-420
16. Takahashl A, Yosimoto H, Mizoi K, Sugawara T, Fujii Y. Transcranial balloon angioplasty for vasospasm after subarachnoid hemorrhage. In: Sano K, ed. Cerebral Vasospasm. Tokyo, Japan: University of Tokyo Press; 1990:429-432
17. Brothers MF, Holgate RC. Intracranial angioplasty for treatment of vasospasm after subarachnoid hemorrhage: technique and modification to improve branch access. AJNR Am J Neuroradiol 1990;11:239-247
18. Higashida RT, Halbach W, Dormandy B, Bell J, Brant-Zawadzki M, Hieshima GB. New microballoon device for transluminal angioplasty of intracranial arterial vasospasm. AJNR Am J Neuroradiol 1990;11:233-238
19. Linskey ME, Horton JA, Rao GR, Yonas H. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. J Neurosurg 1991;74:985-990
20. Kapp J, Mahaley MS Jr, Odom GL. Experimental evaluation of potential spasmolytic drugs. J Neurosurg 1970;32:468-472
21. Nagai H, Noda S, Mabe H. Experimental cerebral vasospasm. Part 2: Effects of vasoactive drugs and sympathectomy on early and late spasm. J Neurosurg 1975;42:420-428
22. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77:842-847
23. Kassel NF, Helm G, Simmons M, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:848-852
24. Marks MP, Steinberg GK, Lane B. Intra-arterial papaverine for the treatment of vasospasm. AJNR Am J Neuroradiol 1993;14:822-826
25. Livingston K, Hopkins LN. Intra-arterial papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol 1993;14:346-347
26. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 1995;16:27-38
27. Eckard DA, Purdy PD, Girson MC, Samson D, Kopitnik T, Batjer H. Intracranial papaverine for relief of catheter-induced intracranial vasospasm. AJR Am J Roentgenol 1992;158:883-884
28. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys, 1: clinical and radiological findings. J Neurosurg 1984;76:1167-1175
29. Zubkov YN, Mikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 1984;70:65-79
30. Gilman AG, Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics. 6th ed. New York, NY: Macmillan; 1980:830
31. Pool JL. Cerebral vasospasm. N Engl J Med 1958;259:1259-1264
32. Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscles. Physiol Rev 1979;59:606-718
33. Tsukahara T, Kongo K, Kassell NF, Ogawa H. The influence of experimental subarachnoid hemorrhage on the relaxation induced by vasoactive intestinal polypeptide in the cerebral arteries of the rabbit. Neurosurgery 1989;24:731-735
34. Bevan JA, Bevan RD, Frazee JG. Functional arterial changes in chronic cerebrovasospasm in monkeys: an in vitro assessment of the contribution to arterial narrowing. Stroke 1987;18:472-481
35. Liszczak TM, Varsos VG, Black PM, et al. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wail. J Neurosurg 1983;58:18-26
36. Varsos VG, Liszczak TM, Han DH, et al. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg 1983;58:11-17
37. Kuwayama A, Zervas NT, Shintani A, Pickren KS. Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm. Stroke 1972;3:27-33